Long-acting medications for the treatment of hyperkinetic disorders -: A systematic review and European treatment guideline.: Part 1:: Overview and recommendations

被引：15

作者：

Banaschewski, Tobias ^{[1
]}

Coghill, David ^{[2
]}

Santosh, Paramala ^{[3
]}

Zuddas, Alessandro ^{[4
]}

Asherson, Philip ^{[5
]}

Buitelaar, Jan ^{[6
]}

Danckerts, Marina ^{[7
]}

Doefner, Manfred ^{[8
]}

Faraone, Stephen V. ^{[9
,10
]}

Rothenberger, Aribert ^{[11
]}

Sergeant, Joseph ^{[12
]}

Steinhausen, Hans-Christoph ^{[13
]}

Sonuga-Barke, Edmund J. S. ^{[14
]}

Taylor, Eric ^{[15
]}

机构：

[1] Zent Inst Seel Gesundheit, Klin Psychiat & Psychotherapie Kindes & Jugendalt, DE-68159 Mannheim, Germany

[2] Univ Dundee, Dept Psychiat, Dundee, Scotland

[3] Hosp Children, Dept Psychol Med, London, England

[4] Univ Calgary, Abt Neurowissensch, Calgary, AB T2N 1N4, Canada

[5] Kings Coll London, Inst Psychiat, MRC Social Genet & Dev Res Ctr, London WC2R 2LS, England

[6] Akad Zentrum Kinder & Jugend Psychiat, Abt Psychiat, Nijmegen, Netherlands

[7] US Gasthuisberg, Abt Kinder & Jugendpsychiat, Louvain, Belgium

[8] Univ Cologne, D-5000 Cologne 41, Germany

[9] SUNY Syracuse, Upstate Med Univ, Med Genet Res Program, Syracuse, NY USA

[10] SUNY Syracuse, Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY USA

[11] Univ Gottingen, Abt Kinder & Jugend Psychiat Psychotherapie, Gottingen, Germany

[12] Free Univ Amsterdam, Fak Psychol & Erziehung, Abt Klin Neuropsychol, Amsterdam, Netherlands

[13] Univ Zurich, Abt Kinder & Jugend Psychiat, CH-8006 Zurich, Switzerland

[14] Univ Southampton, Dept Psychol, Southampton SO9 5NH, Hants, England

[15] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London, England

来源：

ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE | 2008年 / 36卷 / 02期

关键词：

guidelines; stimulants; atomoxetine; ADHD;

D O I：

10.1024/1422-4917.36.2.81

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

A panel of experts from several European countries has accomplished a systematic review of published and unpublished data on the use of long-acting medications in ADHD and hyperkinetic disorder. Based on this analysis detailed recommendations about the use of these drugs in practice have been developed: (1) Long-acting preparations should be licensed and used; (2) They should not completely replace short-acting drugs (which will be the initial treatment for many children in view of cost and the greater flexibility of dosing). Individual clinical choices are necessary. (3) Both ATX and extended-release stimulants should be available. In addition, detailed recommendations will be made with regard to the criteria to be applied in choosing a preparation for the individual patient.

引用

页码：81 / 95

页数：15

共 59 条

[41]

*SIGN, 2001, NAT CLIN GUID, V52

[42] Atomoxetine - A review of its use in adults with attention deficit hyperactivity disorder [J].

Simpson, D ;

Plosker, GL .

DRUGS, 2004, 64 (02) :205-222

[43] Varieties of preschool hyperactivity: multiple pathways from risk to disorder [J].

Sonuga-Barke, EJS ;

Auerbach, J ;

Campbell, SB ;

Daley, D ;

Thompson, M .

DEVELOPMENTAL SCIENCE, 2005, 8 (02) :141-150

[44]

SONUGABARKE E, 2003, EXPERT REV NEUROTHER, V3, P89

[45] A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder [J].

Spencer, T ;

Biederman, J ;

Wilens, T ;

Doyle, R ;

Surman, C ;

Prince, J ;

Mick, E ;

Aleardi, M ;

Herzig, K ;

Faraone, S .

BIOLOGICAL PSYCHIATRY, 2005, 57 (05) :456-463

[46]

SPENCER T, 2004, 157 ANN M AM PSYCH A, P1571

[47] Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study [J].

Spencer, TJ ;

Abikoff, HB ;

Connor, DF ;

Biederman, J ;

Pliszka, SR ;

Boellner, S ;

Read, SC ;

Pratt, R .

CLINICAL THERAPEUTICS, 2006, 28 (03) :402-418

[48]

SUMNER C, 2005, 158 ANN M AM PSYCH A

[49] Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder proof-of-concept and proof-of-product studies [J].

Swanson, J ;

Gupta, S ;

Lam, A ;

Shoulson, I ;

Lerner, M ;

Modi, N ;

Lindemulder, E ;

Wigal, S .

ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (02) :204-211

[50] A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (The COMACS study) [J].

Swanson, JM ;

Wigal, SB ;

Wigal, T ;

Sonuga-Barke, EJS ;

Greenhill, LL ;

Biederman, J ;

Kollins, S ;

Nguyen, AS ;

DeCory, HH ;

Dirksen, SJH ;

Hatch, SJ .

PEDIATRICS, 2004, 113 (03) :E206-E216

← 1 2 3 4 5 6 →